The control of syphilis depends on prompt and accurate diagnosis of all stages of the disease. Although primary syphilis is highly infectious, symptoms may be minimal. Diagnosis by darkfield microscopy is not always possible; therefore, serological tests are of prime importance in the diagnosis of primary syphilis. Nontreponemal (cardiolipin) procedures are used to screen sera for reactivity, whereas treponemal tests, such as the fluorescent treponemal antibody absorption (FTA-ABS) test and the more recently developed microhemagglutination (MHA-TP) test, are used to confirm that the reactivity of nontreponemal methods is specific for syphilis.
In a previous study (4) , the reactivity of the Venereal Disease Research Laboratory (VDRL) nontreponemal test was compared with that of the FTA-ABS and MHA-TP tests in primary syphilis. The MHA-TP test appeared to be a reasonable substitute for the FTA-ABS test, since a high degree of reactivity was observed.
Furthermore, the MHA-TP test confirmed the reactivity in 97% of VDRL-reactive sera. Sera for which the MHA-TP test failed to confirm reactivity were all weakly reactive in the VDRL test. It appeared that the MHA-TP test could be relied upon to confirm most weakly reactive and all VDRL-reactive sera from primary syphilitics. The relationship between the quantitative rapid plasma reagin 18-mm circle card (RPR) test and the MHA-TP test should be determined, because the RPR is also a widely used screening test. Since sera from the previous study (4) were no longer available, a new study was initiated to evaluate the reactivity of the VDRL, RPR, MHA-TP, and FTA-ABS tests in primary syphilis.
MATERIALS AND METHODS
Selection of sera. Sera were saved from patients with a positive dark-field examination. Patients who had primary lesions but were developing secondary manifestations were considered secondary cases. Sera from patients with dark-field-positive, secondary syphilis were eliminated from the study. Medical Fig. 1 and 2 , since relatively small numbers of tests were reflected in each.
The reactivity of sera from 109 patients with first-infection primary syphilis in the VDRL and RPR tests is shown in Fig. 3 . The line in Fig. 3 1:64-
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( (3, 7, 8, 13, 14, 16) , whereas others reported a higher sensitivity (1, 15) . Luger and Spendlingwimmer (9) reported that MHA-TP test reactivity was greater than the FTA-ABS test reactivity in 21 cases of primary syphilis.
The reactivity of the MHA-TP test in the present study conflicts with previous results reported in our laboratory (4). One could speculate that the disagreement in MHA-TP reactivities may be due to differences in patient populations. Fiumara (6) reported that sera from patients with reinfection syphilis exhibited greater seroreactivity than did sera from patients with first-infection syphilis. It is unlikely that reinfection primary syphilis would represent enough cases in any of the studies to influence significantly MHA-TP reactivity. Inclusion of the results for the 18 reinfection syphilis cases we observed during the course of this study would not change the fact that the MHA-TP test failed to react with sera that were from patients with first-infection syphilis and that had significant VDRL or RPR test titers. The variability of lots observed in this study suggests that the reported disagreements over the reactivity of the MHA-TP test in primary syphilis may be due to the variable sensitivity of different lots of reagents.
The failure of some lots of MHA-TP reagents to detect antibodies in first-infection syphilis is puzzling. Proper reactivity with the high-titer serum control should relate the ability of sensitized erythrocytes to detect antibodies to T. pallidum. Perhaps a different immunoglobulin is (1, 4, 9) of high reactivity indicate that some lots of MHA-TP reagents can detect early antibodies to syphilis. The inclusion of low-titer primary syphilitic sera in premarket tests and quality control procedures might ensure the production of a test with consistently high reactivity in primary syphilis.
The high degree of reactivity of the RPR test in primary syphilis was somewhat surprising. Reed (12) suggested that the RPR test was more sensitive than the VDRL test in detecting antibodies to syphilis. Dyckman et al. (5) reported comparable reactivity of the RPR and VDRL tests (64.9 and 63.1%, respectively) with sera from 111 patients with primary syphilis. Wentworth et al. (16) found that 87.1% of 31 sera from patients with primary syphilis were reactive in the RPR test.
Differences in reader interpretations of reactivity could account for the variable reports. Our results, however, suggest that test interpretation is not the reason for the greater sensitivity of the RPR test. One would expect uniformly higher RPR titers, regardless of the VDRL titer, if RPR sensitivity were due to reader error. Perhaps lotto-lot variations occur in the RPR test, accounting for reports of variable reactivity. It is difficult to obtain an accurate history from patients with respect to the time of lesion appearance. It may be possible that sera obtained from patients in the early stages of primary syphilis may have antibodies that are more readily detectable by some tests than by others. This may account for the increased sensitivity of the RPR test.
It can be seen that antibodies to first-infection primary syphilis are more difficult to detect than are antibodies to the later stages of syphilis. Reactivity with serum from an early primary case should be one of the standards against which the efficiency of serological tests for syphilis are established. The inclusion of primary syphilis serum as a test control also is indicated.
